Soares DG - Search Results

1

Sousa FG, Matuo R, Soares DG, Escargueil AE, Henriques JA, Larsen AK, Saffi J. Sousa FG, et al. Among authors: soares dg. Carcinogenesis. 2012 Aug;33(8):1433-40. doi: 10.1093/carcin/bgs132. Epub 2012 Mar 19. Carcinogenesis. 2012. PMID: 22431722 Review.

2

DNA alkylation damage and autophagy induction.

Bordin DL, Lima M, Lenz G, Saffi J, Meira LB, Mésange P, Soares DG, Larsen AK, Escargueil AE, Henriques JAP. Bordin DL, et al. Among authors: soares dg. Mutat Res. 2013 Oct-Dec;753(2):91-99. doi: 10.1016/j.mrrev.2013.07.001. Epub 2013 Jul 18. Mutat Res. 2013. PMID: 23872363 Review.

3

ATP-dependent chromatin remodeling and histone acetyltransferases in 5-FU cytotoxicity in Saccharomyces cerevisiae.

Matuo R, Sousa FG, Bonatto D, Mielniczki-Pereira AA, Saffi J, Soares DG, Escargueil AE, Larsen AK, Henriques JA. Matuo R, et al. Among authors: soares dg. Genet Mol Res. 2013 Apr 26;12(2):1440-56. doi: 10.4238/2013.April.26.6. Genet Mol Res. 2013. PMID: 23661467 Free article.

4

DNA repair pathways involved in repair of lesions induced by 5-fluorouracil and its active metabolite FdUMP.

Matuo R, Sousa FG, Escargueil AE, Soares DG, Grivicich I, Saffi J, Larsen AK, Henriques JA. Matuo R, et al. Among authors: soares dg. Biochem Pharmacol. 2010 Jan 15;79(2):147-53. doi: 10.1016/j.bcp.2009.08.016. Epub 2009 Aug 25. Biochem Pharmacol. 2010. PMID: 19712668

5

Saccharomyces cerevisiae as a model system to study the response to anticancer agents.

Matuo R, Sousa FG, Soares DG, Bonatto D, Saffi J, Escargueil AE, Larsen AK, Henriques JA. Matuo R, et al. Among authors: soares dg. Cancer Chemother Pharmacol. 2012 Oct;70(4):491-502. doi: 10.1007/s00280-012-1937-4. Epub 2012 Aug 1. Cancer Chemother Pharmacol. 2012. PMID: 22851206 Review.

6

Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.

Lima M, Bouzid H, Soares DG, Selle F, Morel C, Galmarini CM, Henriques JA, Larsen AK, Escargueil AE. Lima M, et al. Among authors: soares dg. Oncotarget. 2016 May 3;7(18):25885-901. doi: 10.18632/oncotarget.8292. Oncotarget. 2016. PMID: 27029031 Free PMC article.

7

The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.

Rocca CJ, Poindessous V, Soares DG, Ouadrani KE, Sarasin A, Guérin E, de Gramont A, Henriques JA, Escargueil AE, Larsen AK. Rocca CJ, et al. Among authors: soares dg. Biochem Pharmacol. 2010 Aug 1;80(3):335-43. doi: 10.1016/j.bcp.2010.04.012. Epub 2010 Apr 22. Biochem Pharmacol. 2010. PMID: 20399198

8

Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906.

Soares DG, Battistella A, Rocca CJ, Matuo R, Henriques JA, Larsen AK, Escargueil AE. Soares DG, et al. Biochem J. 2011 Jul 1;437(1):63-73. doi: 10.1042/BJ20101770. Biochem J. 2011. PMID: 21470188 Free article.

9

BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.

Rocca CJ, Soares DG, Bouzid H, Henriques JA, Larsen AK, Escargueil AE. Rocca CJ, et al. Among authors: soares dg. Cell Cycle. 2015;14(13):2080-90. doi: 10.1080/15384101.2015.1042632. Cell Cycle. 2015. PMID: 25945522 Free PMC article.

10

What histone code for DNA repair?

Escargueil AE, Soares DG, Salvador M, Larsen AK, Henriques JA. Escargueil AE, et al. Among authors: soares dg. Mutat Res. 2008 Mar-Apr;658(3):259-70. doi: 10.1016/j.mrrev.2008.01.004. Epub 2008 Jan 20. Mutat Res. 2008. PMID: 18296106 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page